Cleared Traditional

K950522 - CAHP HIGH PERFORMANCE CELLULOSE DIACETATE HOLLOW FIBER DIALYZER

K950522 is an FDA 510(k) clearance for CAHP HIGH PERFORMANCE CELLULOSE DIACETA..., manufactured by Baxter Healthcare Corp. The device is a Class 2 Gastroenterology & Urology device with product code KDI cleared through the Traditional 510(k) pathway after a 80-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1995
Decision
80d
Days
Class 2
Risk

K950522 is an FDA 510(k) clearance for the CAHP HIGH PERFORMANCE CELLULOSE DIACETATE HOLLOW FIBER DIALYZER. Classified as Dialyzer, High Permeability With Or Without Sealed Dialysate System (product code KDI), Class II - Special Controls.

Submitted by Baxter Healthcare Corp (Mcgaw Park, US). The FDA issued a Cleared decision on April 27, 1995 after a review of 80 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5860 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Baxter Healthcare Corp devices

FDA 510(k) Submission Details - K950522

510(k) Number K950522 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 1995
Decision Date April 27, 1995
Days to Decision 80 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 131d · This submission: 80d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KDI Device Classification - Class 2, Special Controls

Product Code KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System

All 304
Devices cleared under the same product code (KDI) and FDA review panel - the closest regulatory comparables to K950522.
ALTRA NOVA(TM) 140 HEMODIALYZER
K945625 · Althin Medical AB an Affiliate of Baxter Intl · May 1995
ALTRA FLUX(TM) 170 HEMODIALYZER
K945542 · Althin Medical AB an Affiliate of Baxter Intl · May 1995
ALTRA FLUX(TM) 140 HEMODIALYZER
K945620 · Althin Medical AB an Affiliate of Baxter Intl · May 1995
ALTREX(R) 200 HEMODIALYZER
K945595 · Althin Medical AB an Affiliate of Baxter Intl · Mar 1995
ALTRES(R) 140 HEMODIALYZER
K945596 · Althin Medical AB an Affiliate of Baxter Intl · Mar 1995
ALTRES(R) 170 HEMODIALYZER
K945597 · Althin Medical AB an Affiliate of Baxter Intl · Mar 1995